TITLE

Securing value in China

AUTHOR(S)
Boswell, Clay; Baker, John
PUB. DATE
October 2006
SOURCE
ICIS Chemical Business;10/2/2006, Vol. 1 Issue 37, p31
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article discusses the status of pharmaceutical firms in China. Despite intellectual property laws, western pharmaceutical companies increasingly regard it as a viable location for cost-effective drug-discovery chemistry. Some firms such as Roche and Eli Lilly are taking a conservative approach, establishing facilities of their own that ensure tight control.
ACCESSION #
22757098

 

Related Articles

  • Lilly Voices Its Concerns About China.  // Chain Drug Review;4/26/2010, Vol. 32 Issue 8, p197 

    The article focuses on the intellectual property rights issue in China which was cited by Eli Lilly and Co.

  • Analysts unfazed by Lilly's freeze. Murphy, Tom // Indianapolis Business Journal;8/30/2004, Vol. 25 Issue 25, p1A 

    Reports on the announcement of a global hiring freeze by Eli Lilly and Co. Impact of the changing market place on the profit margins; Management of the broad patent exposure; Effects of generic competition and price controls on the pharmaceutical company.

  • Lilly and ScinoPharm settle gemcitabine patent litigations.  // PharmaWatch: Cancer;Sep2009, Vol. 8 Issue 9, p18 

    The article reports on the amicable resolution for the patent litigation between Eli Lilly & Co. and ScinoPharm Taiwan Ltd. in the U.S. It states that under the agreement, Lilly will grant the ScinoPharm, a provider of research and development and active pharmaceutical ingredient manufacturing...

  • Depression Update.  // PharmaWatch: CNS;Mar2005, Vol. 4 Issue 3, p11 

    The article offers news briefs related to the pharmaceutical industry. The U.S. Court of Appeals for the Federal Circuit ruled in favor of Pfizer in a lawsuit by generic manufacturer Teva Pharmaceuticals challenging the patent for antidepressant Zoloft. The "British Medical Journal" has...

  • firms, pharmaceutical. Mason, Mike // Globalization & Development: A Glossary;2005, p49 

    An encyclopedia entry for "pharmaceutical firms" is presented. Companies that dominate the pharmaceutical industry include GlaxoSmithKline, Merck, Pfizer and Eli Lilly. The four companies operate like a cartel. During the Uruguay Round of the General Agreement on Tariffs and Trade (GATT)...

  • Industry continues dabbling with open innovation models. Sheridan, Cormac // Nature Biotechnology;Dec2011, Vol. 29 Issue 12, p1063 

    The article highlights several initiatives aimed at improving drug research and development. It reports on the WIPO Re:Search initiative, a collaboration of seven large pharmaceutical companies and biotech firm Alnyulam with the World Intellectual Property Organisation (WIPOO) to share...

  • LILLY'S TERIPARATIDE GETS POSITIVE OPINION FROM CPMP.  // Worldwide Biotech;Feb2003, Vol. 15 Issue 2, p8 

    Reports on the positive opinion issued by the European Committee for Proprietary Medicinal Products concerning the teriparatide (rDNA origin) injection from Lilly.

  • Eli Lilly and Co.  // Indianapolis Business Journal;3/24/2003, Vol. 24 Issue 2, p35 

    Features Eli Lilly and Co., an Indianapolis, Indiana-based pharmaceutical company. Stock value; Major shareholders; Executive compensation; Corporate directors.

  • Lilly looms larger. Jefferson, Greg // Indianapolis Business Journal;07/19/99, Vol. 20 Issue 18, p1A 

    Reports on Indianapolis, Indiana-based drug firm Eli Lilly's expansion plan in Indiana. Company profile; Effect on the cultural and economic makeup of Indiana; Pledge of investments for construction and renovation projects; Projects; Addition of employees. INSET: In first speech to Indy...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics